CRWD insider files Form 144 to sell 40,000 shares
Michael Sentonas reported intent to sell 40,000 shares of Common Stock of CRWD under Section 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Michael Sentonas reported intent to sell 40,000 shares of Common Stock of CRWD under Section 144. The filing lists the proposed sale as Common stock associated with a Performance and Restricted Stock grant dated 03/20/2022.
The filing also discloses recent dispositions: 5,000 shares sold on 05/07/2026 for $2,500,000.00 and 19,367 shares sold on 03/23/2026 for $7,960,999.02. The filing shows 253,614,090 shares outstanding as of 05/11/2026.
Insights
Form 144 notifies the market of an affiliate's planned sale of restricted shares.
The filing lists a proposed disposition of 40,000 restricted Common shares tied to a Performance and Restricted Stock award dated 03/20/2022. Section 144 notice requirements typically precede an open‑market sale or other disposition when applicable holding periods or conditions apply.
Cash‑flow treatment and exact sale mechanics are not shown; subsequent transaction filings or broker confirmations will disclose execution details and final proceeds.
Key Figures
Key Terms
Section 144 regulatory
Performance and Restricted Stock financial
Issuer regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the CRWD Form 144 filed by Michael Sentonas report?
What recent insider sales does the filing disclose for CRWD?
AI-generated analysis. How Rhea-AI works. Not financial advice.